Trimetazidine as adjunctive therapy for decreasing major adverse cardiac events in coronary artery disease patients undergoing reperfusion strategy: a meta-analysis of randomized controlled trials
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
